1. Home
  2. KURA vs METCB Comparison

KURA vs METCB Comparison

Compare KURA & METCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

HOLD

Current Price

$8.91

Market Cap

765.8M

Sector

Health Care

ML Signal

HOLD

Logo Ramaco Resources Inc. Class B

METCB

Ramaco Resources Inc. Class B

HOLD

Current Price

$9.96

Market Cap

725.7M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
KURA
METCB
Founded
2014
2015
Country
United States
United States
Employees
N/A
900
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Coal Mining
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
765.8M
725.7M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
KURA
METCB
Price
$8.91
$9.96
Analyst Decision
Buy
Strong Buy
Analyst Count
11
8
Target Price
$25.56
$34.00
AVG Volume (30 Days)
1.3M
17.5K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
3.70%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$67,482,000.00
N/A
Revenue This Year
$28.28
N/A
Revenue Next Year
$106.37
$13.89
P/E Ratio
N/A
N/A
Revenue Growth
25.24
N/A
52 Week Low
$5.45
$7.13
52 Week High
$12.49
$22.11

Technical Indicators

Market Signals
Indicator
KURA
METCB
Relative Strength Index (RSI) 49.98 41.98
Support Level $8.09 $9.82
Resistance Level $10.34 $11.20
Average True Range (ATR) 0.37 0.68
MACD -0.06 0.00
Stochastic Oscillator 26.25 21.53

Price Performance

Historical Comparison
KURA
METCB

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

About METCB Ramaco Resources Inc. Class B

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. The company's two operating segments are Metallurgical Coal segment; and Rare Earths and Critical Minerals.

Share on Social Networks: